PP
Therapeutic Areas
Mimotopes Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Mimotopes-001 | Solid Tumours (NY-ESO-1 positive) | Phase 1/2 |
| Mimotopes-002 | Non‑Small‑Cell Lung Cancer (PD-L1) | Phase 1 |
| Mimotopes-003 | Multiple Sclerosis | Preclinical |
| Mimotopes-004 | Influenza | Preclinical |